Bridgewater Associates LP Has $30.33 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bridgewater Associates LP decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 40.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 61,740 shares of the medical equipment provider's stock after selling 41,839 shares during the quarter. Bridgewater Associates LP's holdings in Intuitive Surgical were worth $30,331,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock worth $177,000 after buying an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. boosted its stake in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock worth $247,000 after acquiring an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC grew its holdings in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock valued at $653,000 after purchasing an additional 21 shares during the period. Meeder Advisory Services Inc. increased its stake in Intuitive Surgical by 0.3% in the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider's stock valued at $3,629,000 after purchasing an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC raised its holdings in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock worth $310,000 after purchasing an additional 23 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG stock opened at $538.55 on Thursday. The business's fifty day moving average price is $507.94 and its two-hundred day moving average price is $466.79. The stock has a market capitalization of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. Research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company's stock, valued at $402,519.88. This trade represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,459 shares of company stock valued at $26,080,251. 0.80% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. Mizuho raised their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an "overweight" rating in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $526.06.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.